BIOSYNTH

Serial Number 87069542
Registration 5287408
702

Registration Progress

Application Filed
Jun 13, 2016
Under Examination
Jan 17, 2017
Approved for Publication
Nov 22, 2016
Published for Opposition
Nov 22, 2016
Registered
Sep 12, 2017

Basic Information

Serial Number
87069542
Registration Number
5287408
Filing Date
June 13, 2016
Registration Date
September 12, 2017
Published for Opposition
November 22, 2016
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
702
Status Date
Dec 12, 2023
Registration
Registered
Classes
005

Rights Holder

Biosynth AG

03
Address
Rietlistrasse 4
Staad 9422
CH

Ownership History

Biosynth AG

Original Applicant
03
Staad CH

Biosynth AG

Owner at Publication
03
Staad CH

Biosynth AG

Original Registrant
03
Staad CH

Legal Representation

Attorney
Tara Reedy Sliva

USPTO Deadlines

Next Renewal Deadline
796 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-09-12)
Due Date
September 12, 2027
Grace Period Ends
March 12, 2028

Application History

30 events
Date Code Type Description
Dec 12, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 12, 2023 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 12, 2023 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 14, 2023 E815 I TEAS SECTION 8 & 15 RECEIVED
Sep 12, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 18, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 10, 2017 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 9, 2017 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 9, 2017 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 5, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 11, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 11, 2017 EISU I TEAS STATEMENT OF USE RECEIVED
Jul 11, 2017 IUAF S USE AMENDMENT FILED
Jan 17, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2016 PUBO A PUBLISHED FOR OPPOSITION
Nov 22, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 17, 2016 ALIE A ASSIGNED TO LIE
Sep 30, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 27, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED
Sep 27, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED
Sep 22, 2016 DOCK D ASSIGNED TO EXAMINER
Jun 20, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposes, namely, for immunology research; Organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, used as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzyme
First Use Anywhere: Sep 29, 2006
First Use in Commerce: Sep 29, 2006

Classification

International Classes
005